Dr. Anita Goel, MD, Ph.D, is the Founder, Chairman, & CEO of Nanobiosym, advancing nanobiophysics research and commercializing Gene-RADAR® to empower anyone, anywhere, at any-time to access real-time molecular information about their own health. A Harvard-MIT-Stanford trained physicist, physician, inventor, and a world renowned scientist, Dr. Goel has been named by MIT Technology Review as one of the World’s “Top TR35 science and technology innovators” and as one of the "World's Most Influential Visionaries in Biotech" by Scientific American. Dr. Goel has over 70 patents worldwide, has published in top peer-reviewed journals including Nature Group, Scientific American Group and PNAS and has built and led high performance teams of multidisciplinary scientists, engineers, global business executives, globally recognized with top prizes: XPRIZE, 2 USAID Grand Challenge Awards, NASA's Galactic Challenge Award with Elon Musk's SpaceX, 3 DARPA Breakthrough Awards, the first US FDA and ISO 13485 milestones for Gene-RADAR®. Mentored by 2 Nobel Laureates, she holds a Ph.D. in Physics from Harvard, an MD from the Harvard-MIT Joint HST Division, and a B.S. in Physics with Honors and Distinction from Stanford.